User profiles for Sean P Moran

Sean P Moran

Broad Institute of MIT and Harvard
Verified email at broadinstitute.org
Cited by 936

[HTML][HTML] Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

J Maksymetz, SP Moran, PJ Conn - Molecular brain, 2017 - Springer
Support for the N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis of
schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an …

lncRNA DIGIT and BRD3 protein form phase-separated condensates to regulate endoderm differentiation

…, BM Cook, W Li, JV Pondick, SK Gupta, SP Moran… - Nature cell …, 2020 - nature.com
Cooperation between DNA, RNA and protein regulates gene expression and controls
differentiation through interactions that connect regions of nucleic acids and protein domains and …

Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders

SP Moran, J Maksymetz, PJ Conn - Trends in pharmacological sciences, 2019 - cell.com
Muscarinic acetylcholine receptors (mAChR) play important roles in regulating complex
behaviors such as cognition, movement, and reward, making them ideally situated as potential …

M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition

SP Moran, JW Dickerson, HP Cho, Z Xiang… - …, 2018 - nature.com
Highly selective positive allosteric modulators (PAMs) of the M 1 subtype of muscarinic
acetylcholine receptor have emerged as an exciting new approach for improving cognitive …

[PDF][PDF] Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice

…, N Shepard, K Brenner, S Lin, L Herzog, SP Moran… - Neuron, 2023 - cell.com
A genetically valid animal model could transform our understanding of schizophrenia (SCZ)
disease mechanisms. Rare heterozygous loss-of-function (LoF) mutations in GRIN2A, …

A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity

…, HP Cho, PM Garcia-Barrantes, SP Moran… - ACS chemical …, 2018 - ACS Publications
Selective activation of the M 1 subtype of muscarinic acetylcholine receptor, via positive
allosteric modulation (PAM), is an exciting strategy to improve cognition in schizophrenia and …

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256

MD Grannan, CA Mielnik, SP Moran… - ACS chemical …, 2016 - ACS Publications
Abnormalities in the signaling of the N-methyl-d-aspartate subtype of the glutamate receptor
(NMDAR) within cortical and limbic brain regions are thought to underlie many of the …

Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells

…, C Sun, RP Sparks, L Pantano, RU Rahman, SP Moran… - Elife, 2022 - elifesciences.org
Chronic liver injury causes fibrosis, characterized by the formation of scar tissue resulting
from excessive accumulation of extracellular matrix (ECM) proteins. Hepatic stellate cell (HSC) …

M1 muscarinic receptors modulate fear-related inputs to the prefrontal cortex: implications for novel treatments of posttraumatic stress disorder

J Maksymetz, ME Joffe, SP Moran, BJ Stansley, B Li… - Biological …, 2019 - Elsevier
Background The prefrontal cortex (PFC) integrates information from multiple inputs to exert
top-down control allowing for appropriate responses in a given context. In psychiatric …

Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys

…, S Bosinger, Z Johnson, G Tharp, SP Moran… - Brain, behavior, and …, 2016 - Elsevier
Although the most notable clinical symptoms of Huntington’s disease (HD) are motor
disturbances and brain atrophy, other symptoms include cognitive dysfunction, emotional and …